TY - JOUR
TI - DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASH.
AU - Dalamaga, Maria
AU - Liu, Junli
JO - Metabolism open
PY - 2022
VL - 13
TODO - null
SP - 100157
PB - 
SN - null
TODO - 10.1016/j.metop.2021.100157
TODO - Nonalcoholic fatty liver disease, DAPK, Death-associated protein kinase, Death-associated protein kinase-related apoptosis-inducing kinase-2, DRAK2, Nonalcoholic steatohepatitis, Serine/arginine-rich splicing factor 6, Splicing, SRSF6
TODO - null
ER -